Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Academia Sinica, Taiwan

Clinical trials sponsored by Academia Sinica, Taiwan, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New Alzheimer's drug candidate J4 enters first human safety trials Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New Alzheimer's drug candidate J4 enters first human safety trials

Knowledge-focused Recruiting now

This early-stage study tests whether a new drug called J4 is safe for people. It is the first time J4 is given to humans, and only healthy adults aged 18 to 64 can join. The main goal is to check for side effects and how the drug moves through the body. This study does not treat …

Phase 1 • Sponsor: Academia Sinica, Taiwan • Aim: Knowledge-focused

Last updated Jun 27, 2026 08:09 UTC